Description
Semi-quantitative IHC test for PD-L1 (B7-H1, CD274) expression, used to guide treatment with immune checkpoint inhibitors in various cancers, particularly those with high PD-L1 expression.
This lab test includes home sample collection via a provided kit or by a clinician, and you'll receive a comprehensive physical health report with your results.